Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson's Disease (nOH306B). Mov Disord 2015;30:646-54. | USF Parkinson's Disease and Movement Disorders Center

Hauser, RA, S Isaacson, JP Lisk, LA Arthur Hewitt, and G Rowse. 2015. “Droxidopa for the Short-Term Treatment of Symptomatic Neurogenic Orthostatic Hypotension in Parkinson’s Disease (nOH306B). Mov Disord 2015;30:646-54.”. Mov Disord.

Last updated on 10/03/2024